Bayer, Monsanto start $2.5 billion asset sale to get merger clearance: sources

FRANKFURT (Reuters) - German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly $2.5 billion as they seek regulatory clearance for their $66 billion merger, people close to the matter said.

Bayer, Monsanto start $2.5 billion asset sale to get merger clearance: sources
Read More


Bagikan Berita Ini